Title: 3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
Official Title: 3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
Number of Sections: 1
Source: versions - Adopted Amendments
Media Type: application/pdf
Strikethrough Detection: 1 sections found

================================================================================

Section 1:
1 L.D. 538
2 Date: (Filing No. H- )
4 Reproduced and distributed under the direction of the Clerk of the House.
5 STATE OF MAINE
6 HOUSE OF REPRESENTATIVES
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to H.P. 357, L.D. 538, “An Act to Amend
10 Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a
11 Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives”
12 Amend the bill by inserting before section 1 the following:
13 'Sec. 1. 32 MRSA §13794, first ¶, as amended by PL 2019, c. 34, §5, is further
14 amended to read:
15 Every Except as authorized in this section, every drug dispensed pursuant to
16 prescription, whether for a legend drug or not, must carry on the label the following
17 information: the prescription number; the date of filling; the patient's name; directions for
18 use; the name and strength of the drug and the amount dispensed, including either the brand
19 name of the drug or, if a generic and therapeutically equivalent drug or interchangeable
20 biological product is dispensed the label must be in accordance with section 13781; the
21 beyond use date of the drug; the name of the practitioner prescribing the drug; and the
22 name, address and telephone number of the pharmacy where the prescription was
23 compounded and dispensed. For purposes of this section, "beyond use date" means a date
24 beyond which the contents of the prescription are not recommended to be used.'
25 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
26 number to read consecutively.
27 SUMMARY
2288 This amendment, which is the majority report of the committee, clarifies that the
2299 provision in the bill permitting a pharmacist to replace the name of the prescriber with the
3300 name of the health care facility that the prescriber is associated with is an exception to the
3311 requirement in law that the name of the prescriber must be on the label.
Page 1 - 132LR0749(02)
COMMITTEE AMENDMENT
[DELETED: LD:(RC A “ t H 3 L 5 “ A t A0M1P2A3' 4a5E E a a i t s e d d p t6p w f a l d o n m c o t l t f7i8u9n0b1b2n a a t n o t p w t p w3c4b5A6n8T9p0n1r]


================================================================================

Raw Text:
1 L.D. 538
2 Date: (Filing No. H- )
3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
4 Reproduced and distributed under the direction of the Clerk of the House.
5 STATE OF MAINE
6 HOUSE OF REPRESENTATIVES
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to H.P. 357, L.D. 538, “An Act to Amend
10 Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a
11 Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives”
12 Amend the bill by inserting before section 1 the following:
13 'Sec. 1. 32 MRSA §13794, first ¶, as amended by PL 2019, c. 34, §5, is further
14 amended to read:
15 Every Except as authorized in this section, every drug dispensed pursuant to
16 prescription, whether for a legend drug or not, must carry on the label the following
17 information: the prescription number; the date of filling; the patient's name; directions for
18 use; the name and strength of the drug and the amount dispensed, including either the brand
19 name of the drug or, if a generic and therapeutically equivalent drug or interchangeable
20 biological product is dispensed the label must be in accordance with section 13781; the
21 beyond use date of the drug; the name of the practitioner prescribing the drug; and the
22 name, address and telephone number of the pharmacy where the prescription was
23 compounded and dispensed. For purposes of this section, "beyond use date" means a date
24 beyond which the contents of the prescription are not recommended to be used.'
25 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
26 number to read consecutively.
27 SUMMARY
2288 This amendment, which is the majority report of the committee, clarifies that the
2299 provision in the bill permitting a pharmacist to replace the name of the prescriber with the
3300 name of the health care facility that the prescriber is associated with is an exception to the
3311 requirement in law that the name of the prescriber must be on the label.
Page 1 - 132LR0749(02)
COMMITTEE AMENDMENT

[DELETED: LD:(RC A “ t H 3 L 5 “ A t A0M1P2A3' 4a5E E a a i t s e d d p t6p w f a l d o n m c o t l t f7i8u9n0b1b2n a a t n o t p w t p w3c4b5A6n8T9p0n1r]